LAPRETOLIMOD
UNII 6CY69F2AH3

Substance Identification & Data

This profile provides standardized clinical and technical data for Lapretolimod, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6CY69F2AH3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 960324-04-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6CY69F2AH3

CAS Registry Number

960324-04-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LAPRETOLIMOD

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C96H181N2O22P

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JSNQJZJCKAFSHT-OPYGSFAOSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C166928

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

131846121

Unique identification number in the NCBI database of chemical substances.

INN ID

10985

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N(C(C[C@H](OC(CCCCCCCCCCCCC)=O)CCCCCCCCCCC)=O)[C@@H]1[C@@H](OC(C[C@H](OC(CCCCCCCCCCCCC)=O)CCCCCCCCCCC)=O)[C@H](OP(=O)(O)O)[C@H](O[C@H]1OC[C@@H]2[C@@H](O)[C@H](OC(C[C@@H](CCCCCCCCCCC)O)=O)[C@H]([C@H](O2)O)NC(C[C@@H](CCCCCCCCCCC)O)=O)CO

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lapretolimod. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LAPRETOLIMOD

Common Names & Synonyms

GLUCOPYRANOSYL LIPID A

LAPRETOLIMOD [INN]

Systematic Nomenclature

.ALPHA.-D-GLUCOPYRANOSE, 2-DEOXY-6-O-(2-DEOXY-3-O-((3R)-1-OXO-3-((1-OXOTETRADECYL)OXY)TETRADECYL)-2-(((3R)-1-OXO-3-((1-OXOTETRADECYL)OXY)TETRADECYL)AMINO)-4-O-PHOSPHONO-.BETA.-D-GLUCOPYRANOSYL)-2-(((3R)-3-HYDROXY-1-OXOTETRADECYL)AMINO)-, 3-((3R)-3-HYDROXYTETRADECANOATE)

SYS

2-DEOXY-6-O-(2-DEOXY-4-O-PHOSPHONO-2-((3R)-3-(TETRADECANOYLOXY)TETRADECANAMIDO)-3-O-((3R)-3-(TETRADECANOYLOXY)TETRADECANOYL)-.BETA.-D-GLUCOPYRANOSYL)-2-((3R)-3-HYDROXYTETRADECANAMIDO)-.ALPHA.-D-GLUCOPYRANOSE 3-((3R)-3-HYDROXYTETRADECANOATE) IMMUNOMODULATOR, ANTINEOPLASTIC

SYS

External Clinical & Regulatory Resources

Previous UNII6CY6739G7S

Next UNII6CY6HBE01T